Cargando…

Continuous mutation of SARS-CoV-2 during migration via three routes at the beginning of the pandemic

BACKGROUND: It remains unclear how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection started, spread worldwide, and mutated to result in the present variants. This difficulty can be attributed to the limitations associated with the analytical methodology for presenting the diffe...

Descripción completa

Detalles Bibliográficos
Autor principal:	Konishi, Tomokazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976469/ https://www.ncbi.nlm.nih.gov/pubmed/35378929 http://dx.doi.org/10.7717/peerj.12681

Ejemplares similares

The evolution of SARS-CoV-2 and the COVID-19 pandemic
por: Si, Yuanfang, et al.
Publicado: (2023)

Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp
por: Eskier, Doğa, et al.
Publicado: (2020)

Effect of control measures on the pattern of COVID-19 Epidemics in Japan
por: Konishi, Tomokazu
Publicado: (2021)

Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load
por: Eskier, Doğa, et al.
Publicado: (2020)

Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions
por: Farkas, Carlos, et al.
Publicado: (2020)

Genomic diversity of SARS-CoV-2 in Malaysia
por: Mohamad Noordin, Noorliza, et al.
Publicado: (2021)

Benchmark datasets for SARS-CoV-2 surveillance bioinformatics
por: Xiaoli, Lingzi, et al.
Publicado: (2022)

Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity
por: Yang, Chu-Wen, et al.
Publicado: (2021)

Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2
por: Solanki, Vandana, et al.
Publicado: (2021)

The SARS-CoV-2 mutation landscape is shaped before replication starts
por: Masone, Diego, et al.
Publicado: (2023)

Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2
por: Parlikar, Arohi, et al.
Publicado: (2020)

Mutations in SARS-CoV-2 are on the increase against the acquired immunity
por: Konishi, Tomokazu
Publicado: (2022)

PipeCoV: a pipeline for SARS-CoV-2 genome assembly, annotation and variant identification
por: Oliveira, Renato R. M., et al.
Publicado: (2022)

RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look
por: Rangan, Ramya, et al.
Publicado: (2020)

Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection
por: Saçar Demirci, Müşerref Duygu, et al.
Publicado: (2020)

Detection of spreader nodes in human-SARS-CoV protein-protein interaction network
por: Saha, Sovan, et al.
Publicado: (2021)

Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
por: Nersisyan, Stepan, et al.
Publicado: (2022)

EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes
por: Ferreira, Cristina S., et al.
Publicado: (2021)

Early detection of emerging SARS-CoV-2 variants of interest for experimental evaluation
por: Wallace, Zachary S., et al.
Publicado: (2022)

E-Volve: understanding the impact of mutations in SARS-CoV-2 variants spike protein on antibodies and ACE2 affinity through patterns of chemical interactions at protein interfaces
por: Dos Santos, Vitor Pimentel, et al.
Publicado: (2022)

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach
por: Rahman, M. Shaminur, et al.
Publicado: (2020)

Excessive G–U transversions in novel allele variants in SARS-CoV-2 genomes
por: Panchin, Alexander Y., et al.
Publicado: (2020)

Multi-schema computational prediction of the comprehensive SARS-CoV-2 vs. human interactome
por: Dick, Kevin, et al.
Publicado: (2021)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Bioinformatic and Experimental Analysis of T Cell Immune Reactivity to SARS-CoV-2 and its Variants
por: Tarke, Alison, et al.
Publicado: (2022)

Cross-reactivity and inclusivity analysis of CRISPR-based diagnostic assays of coronavirus SARS-CoV-2
por: Khan, Kashif Aziz, et al.
Publicado: (2021)

Effect of SARS-CoV-2 infection on host competing endogenous RNA and miRNA network
por: Ari Yuka, Selcen, et al.
Publicado: (2021)

N-Glycosylation Network Construction and Analysis to Modify Glycans on the Spike (S) Glycoprotein of SARS-CoV-2
por: Krishnan, Sridevi, et al.
Publicado: (2021)

Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses
por: Khadka, Bijendra, et al.
Publicado: (2021)

Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2)
por: Anand, Rajesh, et al.
Publicado: (2020)

Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function
por: Berrio, Alejandro, et al.
Publicado: (2020)

PredictION: a predictive model to establish the performance of Oxford sequencing reads of SARS-CoV-2
por: Valencia-Valencia, David E., et al.
Publicado: (2022)

Performance of methods for SARS-CoV-2 variant detection and abundance estimation within mixed population samples
por: Kayikcioglu, Tunc, et al.
Publicado: (2023)

Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach
por: Mahmud, Shafi, et al.
Publicado: (2021)

Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
por: Yu, Wenhui, et al.
Publicado: (2022)

SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans
por: Konishi, Tomokazu
Publicado: (2021)

Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
por: Shamsi, Anas, et al.
Publicado: (2020)

Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M(pro) inhibitor
por: Kakhar Umar, Abd., et al.
Publicado: (2023)

Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations
por: Akbulut, Ekrem
Publicado: (2022)

Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia
por: Gunadi,, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g1h0jfklof26paub949bkp65li